Notice of Closed Meeting, 8251 [2022-03016]
Download as PDF
<![CDATA[
8251
Federal Register / Vol. 87, No. 30 / Monday, February 14, 2022 / Notices
September 7, 2021 to obtain comments
from the public and affected agencies.
CDC received two non-substantive
comments related to the previous
notice. This notice serves to allow an
additional 30 days for public and
affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary for the
proper performance of the functions of the
agency, including whether the information
will have practical utility;
(b) Evaluate the accuracy of the agencies
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and assumptions
used;
(c) Enhance the quality, utility, and clarity
of the information to be collected;
(d) Minimize the burden of the collection
of information on those who are to respond,
including, through the use of appropriate
automated, electronic, mechanical, or other
technological collection techniques or other
forms of information technology, e.g.,
permitting electronic submission of
responses; and
(e) Assess information collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
HIV Prevention Capacity
Development Needs Assessments of
Federally funded Health Departments
and Community-Based Organizations—
New—National Center for HIV, Viral
Hepatitis, STD, and TB Prevention
(NCHHSTP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The purpose of this data collection is
to determine the training and technical
assistance (TA) needs of health
departments and community-based
organizations (CBO) funded by CDC to
conduct HIV prevention and
surveillance activities. Data will be used
to provide the training and TA funded
agencies need in a timely and efficient
manner by combining the responses and
hosting trainings and TA with multiple
agency staff at the same time.
Data will be gathered by the CDC
through two structured, survey-based
assessments hosted on our online
training and technical assistance request
system. CDC is requesting a three-year
approval in order to accommodate the
multiple Notifications of Funding
Opportunities (NOFO) that inform the
U.S. HIV response system at the local
and state level.
CDC is requests OMB approval for an
estimated 66 annual burden hours.
There are no other costs to respondents
other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Community-based Organization Representatives—Adults.
Health Department Representatives—Adults
Community-based Organization Needs Assessment.
Health Department Needs Assessment .........
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–03075 Filed 2–11–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
jspears on DSK121TN23PROD with NOTICES1
Number of
respondents
Type of respondent
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
VerDate Sep<11>2014
17:54 Feb 11, 2022
Jkt 256001
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease, Disability,
and Injury Prevention and Control Special
Emphasis Panel (SEP)—RFA–CK22–006,
Clinical and Applied Research Strategies for
the Prevention and Control of Fungal
Diseases.
Date: April 14, 2022.
Time: 10:00 a.m.–5:00 p.m., EDT.
Place: Teleconference, Centers for Disease
Control and Prevention, Atlanta, GA 30329.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Gregory
Anderson, M.S., M.P.H., Scientific Review
Officer, CDC, National Center for HIV, Viral
Hepatitis, STD, and TB Prevention, 1600
PO 00000
Frm 00025
Fmt 4703
Sfmt 9990
Number of
responses per
respondent
Average
burden per
response
(in hours)
130
1
15/60
70
1
15/60
Clifton Road NE, Mailstop US8–1, Atlanta,
Georgia 30329, (404) 718–8833, ganderson@
cdc.gov.
The Director, Strategic Business Initiatives
Unit, Office of the Chief Operating Officer,
Centers for Disease Control and Prevention,
has been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–03016 Filed 2–11–22; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\14FEN1.SGM
14FEN1
]]>Agencies
[Federal Register Volume 87, Number 30 (Monday, February 14, 2022)]
[Notices]
[Page 8251]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-03016]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention
and Control Special Emphasis Panel (SEP)--RFA-CK22-006, Clinical and
Applied Research Strategies for the Prevention and Control of Fungal
Diseases.
Date: April 14, 2022.
Time: 10:00 a.m.-5:00 p.m., EDT.
Place: Teleconference, Centers for Disease Control and
Prevention, Atlanta, GA 30329.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, National Center for HIV, Viral
Hepatitis, STD, and TB Prevention, 1600 Clifton Road NE, Mailstop
US8-1, Atlanta, Georgia 30329, (404) 718-8833, [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-03016 Filed 2-11-22; 8:45 am]
BILLING CODE 4163-18-P
